Blumont's staggering stock performance raises many questions
INVESTORS of Blumont Group, whose stock is arguably one of the best performing this year, would be laughing all the way to the bank had they held on to the shares they bought early this year.
After hovering at around 20 to 30 cents in late 2012, the stock has been heading northwards this year, ending at $2.39 yesterday despite shedding five cents. This even after the stock traded ex-entitlement on Sept 19 for a 1-for-2 rights issue at five cents. Some label it a darling stock, citing the volumes that accompanied the sharp spike of late.
So what exactly is this gem of an investment?
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance